Supply and delivery of contraceptives and hormone modulating agents to the department of health (HP03-2026CHM/01)

The bidder must indicate the type of single bidding enterprise by marking the relevant option: close corporation, company, incorporated joint venture, or listed company.

Returnable documents: PBD9.1 (Directors Categorisation) must be completed and submitted with the bid.

No eligibility criteria specified

Cell G2: Ownership or Director in related enterprise/s whether or not such enterprise/s are bidding in this tender? (Y/N)

Bidders must complete PBD9.1, disclosing full names, surnames, nationalities, identity or passport numbers of directors, whether they are appointed as directors, whether they are executive or non-executive directors, and whether they hold ownership or directorship in related enterprises bidding in this tender.

This annexure defines the minimum data fields that must appear on every invoice submitted for products delivered under this contract. It covers the invoice header, supplier and contact information, delivery details, invoice and order references, line-item data, summary totals, pay office details, and proof-of-delivery records.

{"closingDate":"30 SEPTEMBER 2029"}

{"name":null,"email":null,"phone":null,"department":"OF HEALTH FOR THE PERIOD ENDING 30 SEPTEMBER 2029","address":"ibutor name Name of authorised distributor"}

Bidders must be registered on the Central Supplier Database (CSD) and have a valid CSD registration number (MAAA). Bidders must have a valid VAT registration number. Bidders must have a company registration number. Bidders must have a valid tax clearance (implied by VAT and CSD requirements).

7.3 Brand Name As per Contract Circular and Purchase Order

7.4 Name of Contract, relevant addenda (for prices) and

item number as per Contract Circular:

E.g. HP13-2013ARV_04_001

Contract#_Addendum#_It

em# The addenda number should have two placeholders

The item number should have three place holders

Item number should correspond

with Generic Product Description

7.5 Quantity Ordered Original requested quantity as per Purchase Order

7.6 Quantity Supplied The quantity of product delivered on this invoice

7.7 Batch number If there are multiple batch number per product then

each batch must appear on a separate line with the

appropriate quantity

7.8 Expiry If there are multiple expiry dates per product then

each expiry must appear on a separate line with the

appropriate quantity

7.9 Unit price (VAT INC) Unit Price as per Contract Circular or addendum which

includes VAT and delivery, must be to 4 (four) decimal

points.

7.10 Total Unit Price multiplied by the delivered quantity

Summary invoice line information

8 Field Definition

8.1 Total Ex VAT To 2 (two) decimal points

8.2 VAT amount To 2 (two) decimal points

8.3 Total Sum of Ex and VAT, to 2 (two) decimal points

'

Page | 3

HP03-2026CHM/01: supply and delivery of contraceptives and hormone modulating

Agents to the department of health for the period ending 30 september 2029

‘Invoice To' information

9 Field Definition

9.1 Pay office Name Name of the entity holding the budget as per Purchase

Order Invoice To address

9.2 Pay office Address Address of the Invoice To entity as per Purchase

Order.

9.3 VAT # The VAT registration number of the entity buying the

goods as per Purchase Order

9.4 Pay Office Phone Telephone number of the Invoice To entity as per

Purchase Order

‘Goods Received By' information (Proof Of Delivery information)

10 Field Definition

10.1 Date Date goods were received

10.2 Name Print Name of person receiving and

singing for goods

10.3 PERSAL # PERSAL number of person receiving and signing for

goods.

10.4 Signature Signature of person receiving and signing for goods.

10.5 Number Cartons Received Indicate the number of cartons received for the invoice.

10.6 Facility stamp Sufficient space to allow the facility to stamp the

invoice without obscuring any detail on the invoice.

10.7 GRV number Space for Goods Received Voucher number to be

recorded on the invoice

10.8 Claim Reference Number Number of claim reference associated with delivery if

relevant

Page | 4

CSD registration number For Supplier name on contract

Invoices for products delivered under this contract must include all fields specified in the Invoice Minimum Data Requirements. Each invoice must carry a header identifying it as a tax invoice, a supplier copy, or a customer copy. Supplier details must reflect the contracted supplier, not the distributor, and include the NDoH supplier code, CSD registration number, company registration number, and VAT number. The 'Deliver To' block must show the facility name, demander code, MHFL code, delivery address, and the name and phone of the person authorised to receive delivery. Each invoice must reference a single purchase order number, with the order captured date and any special instructions. Line items must show the EAN-13 barcode, generic product description, brand name, contract and item number, quantity ordered and supplied, batch number, expiry date, unit price including VAT and delivery (to four decimal places), and the total price. Summary totals must show the amount excluding VAT, the VAT amount, and the total, each to two decimal places. The 'Invoice To' block must show the pay office name, address, VAT number, and phone. Proof of delivery must record the date, the name and PERSAL number of the receiving person, their signature, the number of cartons received, space for the facility stamp, the GRV number, and any claim reference.

{"name":null,"email":null,"phone":null,"department":null,"address":"or member."}

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. Bidders must submit a valid QSE/EME sworn affidavit to claim these points. An incorrectly completed affidavit is invalid and no preference points will be allocated.

B-BBEE status: Bidders with annual turnover above R50 million must submit a valid SANAS-accredited B-BBEE certificate and cannot use a QSE/EME affidavit. QSEs (turnover R10–R50 million) and EMEs (turnover under R10 million) may submit a sworn affidavit. The affidavit must be completed correctly, including: deponent's name and ID number, designation (director, owner, or member), enterprise name and address as per CIPC registration, percentages of black ownership, black female ownership, and designated group ownership, total revenue and its basis (audited or management accounts), financial year end, B-BBEE status level, empowering supplier status, matching signature dates, and a Commissioner of Oaths who is not an employee or ex officio of the enterprise.

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. A correctly completed QSE/EME sworn affidavit is required; an invalid affidavit means no preference points are awarded.

Supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029. Bid number HP03-2026CHM/01.

Closing date: 5 October 2026 at 11:00. Non-compulsory online briefing session via MS Teams on 18 September 2026 at 10:00.

Bidding process and technical enquiries: [email protected]. Directorate: Access to Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria, Tel: (012) 395 8130, Fax: (012) 395 8823/4.

Bids must be delivered to the Tender Box at the Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, before the closing time. Late bids will not be accepted. All bids must be submitted on the official forms provided, not re-typed. Required returnable documents include: SBD 1 (Invitation to Bid), SBD 4 (Declaration of Interest), SBD 6.1 (Preference Points Claim), SBD 5 (NIP Programme), PBD 3/3.1 (Bid Signature Authorisation), PBD 8 (Declaration of Compliance with SRCC and GCC), PBD 11 (Declaration of Financial Solvency and Business Rescue Status), PBD 5 (GMP Declaration), PBD 1 (Authorisation Declaration), and proof of tax compliance (SARS PIN or CSD number). Bids from persons in the service of the state, or companies with such directors, will not be considered.

Bid documents must be submitted on official forms. Required documents include: Bid Document Checklist (Paragraph 3), Bid Documents (Paragraph 4.1), Consortium/JV/Partnership details (Paragraph 4.3), Submission of bids (Paragraph 9), Completion and submission (Paragraph 10).

The 90/10 preference point system applies. Price: 90 points. Specific goals (B-BBEE status level of contributor): 10 points. B-BBEE points: Level 1=10, Level 2=9, Level 3=8, Level 4=6, Level 5=5, Level 6=4, Level 7=3, Level 8=2, non-compliant=0. The specific goal is the promotion of companies with higher B-BBEE contribution levels (Status Levels 1-4). Failure to submit proof of B-BBEE status will result in zero preference points, but will not render the bid non-responsive.

Supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029. The bid validity period is 180 days. Products must comply with the Medicines and Related Substances Act. Bidders must declare GMP compliance and undertake to inform the Department of Health of any circumstances that may result in interrupted supply.

Bidders must declare GMP compliance (PBD 5): no outstanding GMP or legal matters, compliance with the Medicines and Related Substances Act, and an undertaking to inform the Department of Health of any circumstances that may result in interrupted supply.

Bidders must declare financial solvency and that they are not under business rescue, liquidation, or similar proceedings. They must notify the Department within 5 working days of any material financial event. A performance guarantee may be required under the NIP Programme for contracts with imported content exceeding US$10 million.

Tax compliance: submit SARS TCS PIN or CSD number; each consortium/JV/subcontractor must submit separate TCS. B-BBEE: claim via SBD 6.1, supported by a valid SANAS accredited B-BBEE certificate or sworn affidavit for EME/QSE. GMP: PBD 5 declaration of compliance with the Medicines and Related Substances Act. Financial solvency: PBD 11 declaration. NIP: SBD 5 for contracts with imported content. Bids from persons in the service of the state are disqualified.

B-BBEE preference points are claimed via SBD 6.1. Proof required: valid SANAS accredited B-BBEE certificate or sworn affidavit for EME/QSE. The specific goal is the promotion of companies with higher B-BBEE contribution levels (Status Levels 1-4).

The contract is subject to the General Conditions of Contract (GCC) and Special Requirements and Conditions of Contract (SRCC). Bidders must declare compliance via PBD 8. The bidder must be financially solvent and not under business rescue or liquidation (PBD 11). The NIP Programme may impose obligations for contracts with imported content, including a performance guarantee to the DTI.

The National Industrial Participation (NIP) Programme applies to contracts with imported content. The obligation is triggered if imported content equals or exceeds US$10 million (or multiple contracts exceeding US$3 million each over 2 years). The NIP obligation is 30% of imported content. Successful bidders with contracts over R10 million must report to the DTI within 5 working days. Contact: Ms R Muthan, (012) 394 1288, [email protected].

Bids must be delivered by the stipulated time to the correct address; late bids will not be accepted. Bids must be on official forms. Tax compliance: submit SARS PIN or CSD number; each consortium/JV/subcontractor must submit separate TCS. Bids from persons in the service of the state or companies with such directors will not be considered.

The tender is for the supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029. Bidders must complete PBD 9.2, which requires details of all directors for each entity in the bidding enterprise.

Returnable documents: PBD 9.2 (Directors Categorisation for Multi-Entity Bidding Enterprises) must be completed and submitted. The form requires details of all directors for each entity in the bidding enterprise, including full names, surnames, entity designation (A, B or C), nationality, identity or passport number, director appointment status, executive or non-executive status, and any other directorships or ownership in other enterprises.

Bidders must be registered on the Central Supplier Database (CSD) and provide their CSD registration (MAAA) number. Multi-entity bidders must provide CSD registration for each entity (Entity A, B, C).

Bidders must provide details of all directors for each entity in the bidding enterprise, as required by PBD 9.2.

The tender is for the supply and delivery of contraceptives and hormone modulating agents to the Department of Health for a period ending 30 September 2029. The bid response spreadsheet lists 17 items with specifications, therapeutic class numbers, units, estimated quantities, and required pricing and product information.

Bidders must complete and submit the bid response spreadsheet (HP03-2026CHM_01_Bid Response) with all required fields per item, including delivered prices in ZAR to two decimals, product registration numbers, licence to manufacture medicines details, pack sizes, lead times, batch capacity, barcodes, NAPPI codes, distributor and manufacturer details, API sources, and cost breakdown percentages. If any listed manufacturer is a third party, PBD1 must be completed. Standard SBD forms must be completed and signed as applicable. Prices may not exceed the SEP (current listing corresponding unit).

Bidders must be registered on the Central Supplier Database (CSD) and provide their CSD number. Bidders must hold a valid licence to manufacture medicines, with licence number and expiry date provided. Bidders must have product registration numbers for each item. Bidders must comply with the pricing requirement that delivered prices do not exceed the SEP. Bidders must complete the bid response spreadsheet and any required standard forms (e.g., SBD forms) as applicable. Bidders must indicate whether any listed manufacturers are third parties and, if so, complete PBD1.

The tender covers the supply and delivery of contraceptives and hormone modulating agents. Items include: tubal occlusion clips (sterile, X-ray detectable); clomifene 50mg tablets (packs of 5 and 10); conjugated estrogens 0.3mg and 0.625mg tablets (packs of 28); levonorgestrel 0.03mg tablets (28-tablet calendar pack); levonorgestrel and ethinylestradiol triphasic tablets (28-tablet calendar pack); medroxyprogesterone acetate 104mg/0.65mL suspension for subcutaneous injection (single-dose disposable injector); norethisterone and estradiol tablets (28-tablet calendar pack); norgestrel and estradiol valerate tablets (28-tablet calendar pack); norgestrel and ethinylestradiol monophasic tablets (28-tablet calendar pack); fallopian tube rings (silastic, sterile, radio-opaque, one guide per 50 pairs); dinoprostone 0.5mg scored tablets (packs of 10); testosterone 1g injection; conjugated oestrogens 0.625mg/g vaginal cream (42.5g each); dinoprostone 1mg/3g gel for endocervical application (sterile peel pack). Estimated quantities for the full tender period are specified per item, ranging from 1,300 pairs of clips to 9,174,090 packs of levonorgestrel/ethinylestradiol triphasic tablets.

Bidders must provide delivered prices in ZAR to two decimals for each item. Prices may not exceed the SEP (current listing corresponding unit). Bidders must also provide a delivered price per shipper pack. Cost breakdown percentages must be provided for API, formulation, packaging, logistics, and gross margin, indicating local vs imported portions. Currency must be specified (ZAR, USD, GBP, EURO, DKK, CHF, AUD, INR, Yuan, or Other).

The tender covers the supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029. Bidders must ensure their tax status, licences to manufacture, and certificates are in order.

Bidders must submit all documents sorted and filed in the exact order listed in the bid document index. Each document must be labelled with its admin code. The signed Excel pricing schedule is mandatory; if it is not signed, the bid will not be considered for evaluation. Two USB flash drives with a digital copy of the completed bid must be provided, with each compilation sequence saved as a separate file named using the admin code abbreviations. If a document is not applicable, the bidder must explicitly indicate 'N/A' and provide justification; blacking out the N/A field is not acceptable. Required returnable forms include: PBD3 (Bid Signature Authorisation, original or certified copy), SBD1 (Invitation to Bid), SBD4 (Bidder's Disclosure), SBD6.1 (Preference Points Claim), PBD11 (Declaration of Financial Solvency and Business Rescue Status), PBD5 (GMP Declaration of Compliance), SBD5 (National Industrial Participation Programme), PBD8 (SRCC and GCC Declaration of Compliance), and the SRCC and GCC documents initialled on every page.

The evaluation will consider mandatory documents and preference points. Bidders must submit a valid B-BBEE certificate (SANAS accredited) or sworn affidavits for EME/QSE where applicable. Preference points are claimed via SBD6.1. The specific scoring split (80/20 or 90/10) is not stated in the provided text.

The tender is for the supply and delivery of contraceptives and hormone modulating agents to the Department of Health. Bidders must hold valid licences to manufacture or import the offered products, including all annexures, and provide certified copies. Medicine Registration Certificates (MRCs) must be marked with the relevant item number and filed in numerical order. A valid Variation Summary is required for any changes to MRCs as prescribed by SAHPRA guidelines. The original Package Insert (PI) with QR code and professional information approved by the MCC or SAHPRA must be submitted for each product offered. Proof of sample submission is required.

Mandatory compliance documents include: CSD registration report, SARS Tax Clearance Pin, CIPC registration certificate, and, where applicable, CIPC notice of change in directors and proof of company ceding, mergers, acquisitions, or name changes. Bidders must provide identification documents of directors as per PBD9.1 or PBD9.2. A valid licence to manufacture or import (LICMI) is mandatory, and for locally produced products, a licence for local manufacturing sites (LICM) is required. Licences for complementary medicines (LICCM) and medical devices or IVDs (LICMD) are mandatory where applicable. Multi-entity bids require a certified copy of the partnership, joint venture, or consortium agreement. Bidders must submit a valid B-BBEE certificate (SANAS accredited) or sworn affidavits for EME/QSE where applicable.

The tender is for the supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029.

Closing date and time: 5 October 2026 at 11:00 am. A non-compulsory online briefing session will be held via MS Teams on 18 September 2026 at 10H00. Bidders who wish to participate may join using the provided link. The bid document will be published on the website on 4 September 2026.

A non-compulsory online briefing session will be held via MS Teams on 18 September 2026 at 10H00. Bidders who wish to participate may join using the provided link.

All enquiries regarding this bid must be emailed to [email protected]. Office hours are 07h30 to 15h30.

Bids must be delivered to the DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143, before the closing time of 11:00 am on 5 October 2026. The bid document is available for download from the Department of Health website (www.health.gov.za) under the 'TENDERS' tab and then 'PHARMACEUTICAL TENDERS' tab, and from the e-tender portal on the National Treasury website. All enquiries must be submitted to [email protected] in time to allow responses before the tender closes. The department strongly recommends that bidders submit all enquiries, including any problems experienced with the registration process, early. Bids must include all mandatory administrative documents as required in the bid document.

The bid will be evaluated in four phases: Phase I – compliance with mandatory administrative bid requirements; Phase II – compliance with product, technical and legal mandatory requirements; Phase III – evaluation of B-BBEE compliance as per Section 9 of the Special Requirements and Conditions of Contract (SRCC); Phase IV – recommendation and award. Bidders must comply with B-BBEE requirements as per Section 9 of the SRCC.

The scope is the supply and delivery of contraceptives and hormone modulating agents to the Department of Health for the period ending 30 September 2029. Bidders must comply with product, technical and legal mandatory requirements as evaluated in Phase II.

Bidders must comply with B-BBEE requirements as per Section 9 of the Special Requirements and Conditions of Contract (SRCC). The bid document includes mandatory administrative requirements that must be met in Phase I. Bidders must also comply with product, technical and legal mandatory requirements in Phase II.

The bid will be evaluated in four phases: Phase I – compliance with mandatory administrative bid requirements; Phase II – compliance with product, technical and legal mandatory requirements; Phase III – evaluation of B-BBEE compliance as per Section 9 of the Special Requirements and Conditions of Contract (SRCC); Phase IV – recommendation and award.